Phosphorothioate oligodeoxyribonucleotides dissociate from cationic lipids before entering the nucleus.
about
Translation of stable hepadnaviral mRNA cleavage fragments induced by the action of phosphorothioate-modified antisense oligodeoxynucleotidesQuantitative nuclear and cytoplasmic localization of antisense oligonucleotides by capillary electrophoresis with laser-induced fluorescence detection.Inhibition of the human chemokine receptor CXCR4 by antisense phosphorothioate oligodeoxyribonucleotides.Efficient gene silencing by delivery of locked nucleic acid antisense oligonucleotides, unassisted by transfection reagents.Lipid-based systems for the intracellular delivery of genetic drugs.Molecular therapy in ocular wound healing.Controlling the mitochondrial gatekeeper for effective chemotherapy.Subcellular trafficking of antisense oligonucleotides and down-regulation of bcl-2 gene expression in human melanoma cells using a fusogenic liposome delivery system.Vehicles for oligonucleotide delivery to tumours.Therapeutic potential of antisense oligonucleotides as modulators of alternative splicing.LNA-based oligonucleotide electrotransfer for miRNA inhibition.Cell-specific targeting of lipid-based carriers for ODN and DNA.Nanoplasmonic gene regulationSub-cellular temporal and spatial distribution of electrotransferred LNA/DNA oligomerBioconjugation of oligonucleotides for treating liver fibrosis.Identification and characterization of intracellular proteins that bind oligonucleotides with phosphorothioate linkages.TCP1 complex proteins interact with phosphorothioate oligonucleotides and can co-localize in oligonucleotide-induced nuclear bodies in mammalian cells.Cellular penetration and antisense activity by a phenoxazine-substituted heptanucleotide.Efficient cationic lipid-mediated delivery of antisense oligonucleotides into eukaryotic cells: down-regulation of the corticotropin-releasing factor receptor.Histidylated oligolysines increase the transmembrane passage and the biological activity of antisense oligonucleotidesEnhanced delivery of antisense oligonucleotides with fluorophore-conjugated PAMAM dendrimers.Cationic porphyrins: novel delivery vehicles for antisense oligodeoxynucleotides.Sequence-dependent cytotoxicity of second-generation oligonucleotides.Regulation of lipoprotein lipase by protein kinase C alpha in 3T3-F442A adipocytes.Antisense oligonucleotide and thyroid hormone conjugates for obesity treatmentTargeted delivery of antisense oligonucleotides to hepatocytes using triantennary N-acetyl galactosamine improves potency 10-fold in mice.Poly(propylacrylic acid) enhances cationic lipid-mediated delivery of antisense oligonucleotides.Cellular pathway of plasmids vectorized by cholesterol-based cationic liposomes.Intravenously administered oligonucleotides can be delivered to conducting airway epithelium via the bronchial circulation.Oligonucleotide therapies for disorders of the nervous system.Liposomal Spherical Nucleic Acids for Regulating Long Noncoding RNAs in the Nucleus.
P2860
Q24793675-B8DBE2F8-A7F6-47A9-BE13-57467E881555Q30667117-9BD4525A-DD7C-42F1-9A95-C3B2112EB4BAQ31864643-B39D1090-C9F3-404D-8998-937875423162Q33566440-E4CEB757-72D4-43E2-91D6-E97C10364E9BQ33637982-120B00EC-9585-4475-8478-3EB0B8D31487Q33760306-D8DB9009-EEC6-43CB-9A1E-A760952C0592Q34089134-A35C7D3D-936D-4AB9-BE1B-E30B7422A5A7Q34366036-873547EF-A939-4630-8FDF-1AD954760290Q34518719-6FF4D2A1-CB08-489F-95D1-ED8215A3EDF5Q35202466-782CDDBE-9047-4DD6-9D09-870019A0308BQ36142470-B84AA34A-5B70-40DF-9FD2-18C7E62F61E3Q36272601-3A680D6B-46D4-4C30-BCDB-FF341928F713Q36733287-5A312D73-86B9-4642-AB92-47FDEF75F896Q37029450-C60A9C2A-CA09-4BC4-A350-09E2E98836B2Q37043515-D8B4390C-C5A4-4971-A48F-6755640D34FCQ38300866-C1BD81FC-A9CA-42F9-9542-2D588E18F147Q38306837-4184336B-8B31-428E-84B1-C65DD73C3F6CQ38329058-241A05DB-87EF-409F-8E0B-805FCB2B0CCFQ39085570-E3669B2B-6CDE-4AB9-BFD2-1FBE9B7F20D5Q39541959-97F023FF-11CB-4C57-9597-40D6D254B609Q39551065-02CBE464-E4B7-40EA-9AC5-4F592DE87AF3Q39725869-D6E56BFC-CBDC-4D7E-B591-7E484B39A5CFQ40479775-BD5DDE80-EAE3-4D49-A116-21EAB5AE0BCDQ40714360-4CD1147D-B0D3-4E30-9926-694B6DBAFDE5Q41517624-B4951BE0-6C28-404B-9C3B-760285D6B686Q41846059-D4D31F18-336B-434C-84B1-5DDEC1A82FBBQ42418345-9579037C-95C3-4494-82F6-C42D5043A8E6Q44031906-C5B1DC4C-3304-4F29-813C-A279B838C914Q45859210-D45CCCDD-429C-47D0-AADB-76A67B426D81Q48288187-2F63E840-9FF4-46ED-B921-7A3512A41CFEQ48887906-491FD463-402B-4283-941B-3A99025D82CB
P2860
Phosphorothioate oligodeoxyribonucleotides dissociate from cationic lipids before entering the nucleus.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
Phosphorothioate oligodeoxyrib ...... s before entering the nucleus.
@en
Phosphorothioate oligodeoxyrib ...... s before entering the nucleus.
@nl
type
label
Phosphorothioate oligodeoxyrib ...... s before entering the nucleus.
@en
Phosphorothioate oligodeoxyrib ...... s before entering the nucleus.
@nl
prefLabel
Phosphorothioate oligodeoxyrib ...... s before entering the nucleus.
@en
Phosphorothioate oligodeoxyrib ...... s before entering the nucleus.
@nl
P2093
P2860
P356
P1476
Phosphorothioate oligodeoxyrib ...... s before entering the nucleus.
@en
P2093
C F Bennett
E G Marcusson
M Manoharan
P2860
P304
P356
10.1093/NAR/26.8.2016
P407
P577
1998-04-01T00:00:00Z